Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CRIADO, Pilar LOPEZ
Neo-DREAM, NCT03567889: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients	Recruiting	3	186	Europe, US	Daromun, Surgery, Adjuvant therapy	Philogen S.p.A.	Melanoma Stage IIIB/C	06/24	06/26
PEACE2, NCT01952223 / 2012-000566-38: A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse	Active, not recruiting	3	761	Europe	Cabazitaxel, jevtana, Pelvic radiotherapy, prostate radiotherapy	UNICANCER, Sanofi	Adenocarcinoma of Prostate, Progression of Prostate Cancer	12/25	07/41
KEYNOTE-E72, NCT06016920: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma	Recruiting	1/2	51	Europe, RoW	VB10.16, Pembrolizumab, KEYTRUDA®	Nykode Therapeutics ASA, Merck Sharp & Dohme LLC	HPV-Related Squamous Cell Carcinoma, HNSCC	09/27	01/28